Codon pairs of the HIV-1 vif gene correlate with CD4+ T cell count

BMC Infectious Diseases

Volumn 13, Issue 1, 2013, Pages

  Bizinoto, Maria Clara ^a   Yabe, Shiori ^b   Leal, Élcio ^c   Kishino, Hirohisa ^b   Martins, Leonardo de Oliveira ^d   de Lima, Mariana Leão ^a   Morais, Edsel Renata ^a   Diaz, Ricardo Sobhie ^a   Janini, Luiz Mário ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSITY OF TOKYO   (Japan)

^c FEDERAL UNIVERSITY OF PARÁ   (Brazil)

^d UNIVERSITY OF VIGO   (Spain)

Author keywords

APOBEC; Co evolution; Epistasis; HIV 1; Hypermutation; Positive selection; Vif

Indexed keywords

VIF PROTEIN; VIRUS RNA;

AMINO ACID SUBSTITUTION; AMINO TERMINAL SEQUENCE; ARTICLE; CD4 LYMPHOCYTE COUNT; CODON; COEVOLUTION; CONTROLLED STUDY; EPISTASIS; EVOLUTIONARY ADAPTATION; FEMALE; GENE CLUSTER; GENE LOCATION; GENE SEQUENCE; GENETIC ASSOCIATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; MAJOR CLINICAL STUDY; MALE; MOLECULAR RECOGNITION; PROTEIN DEGRADATION; PROTEIN RNA BINDING; SEQUENCE ALIGNMENT; VIF GENE; VIRUS GENE;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; CD4 LYMPHOCYTE COUNT; CD4-POSITIVE T-LYMPHOCYTES; CYTIDINE DEAMINASE; CYTOSINE DEAMINASE; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; MALE; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; PROTEIN BINDING; PROTEIN CONFORMATION; RNA, VIRAL; VIF GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS;

EID: 84875919501     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-13-173     Document Type: Article

References (53)

1. Henriet S, Richer D, Bernacchi S, Decroly E, Vigne R, Ehresmann B, Ehresmann C, Paillart JC, Marquet R. Cooperative and specific binding of Vif to the 5' region of HIV-1 genomic RNA. J Mol Biol 2005, 354(1):55-72. 10.1016/j.jmb.2005.09.025, 16236319.
2. Chiu YL, Greene WC. The APOBEC3 cytidine deaminases: an innate defensive network opposing exogenous retroviruses and endogenous retroelements. Annu Rev Immunol 2008, 26:317-353. 10.1146/annurev.immunol.26.021607.090350, 18304004.
3. Sheehy AM, Gaddis NC, Choi JD, Malim MH. Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein. Nature 2002, 418(6898):646-650. 10.1038/nature00939, 12167863.
4. Esnault C, Heidmann O, Delebecque F, Dewannieux M, Ribet D, Hance AJ, Heidmann T, Schwartz O. APOBEC3G cytidine deaminase inhibits retrotransposition of endogenous retroviruses. Nature 2005, 433(7024):430-433. 10.1038/nature03238, 15674295.
5. Pace C, Keller J, Nolan D, James I, Gaudieri S, Moore C, Mallal S. Population level analysis of human immunodeficiency virus type 1 hypermutation and its relationship with APOBEC3G and vif genetic variation. J Virol 2006, 80(18):9259-9269. 10.1128/JVI.00888-06, 1563905, 16940537.
6. Kobayashi M, Takaori-Kondo A, Miyauchi Y, Iwai K, Uchiyama T. Ubiquitination of APOBEC3G by an HIV-1 Vif-Cullin5-Elongin B-Elongin C complex is essential for Vif function. J Biol Chem 2005, 280(19):18573-18578. 10.1074/jbc.C500082200, 15781449.
7. Marin M, Rose KM, Kozak SL, Kabat D. HIV-1 Vif protein binds the editing enzyme APOBEC3G and induces its degradation. Nat Med 2003, 9(11):1398-1403. 10.1038/nm946, 14528301.
8. Sheehy AM, Gaddis NC, Malim MH. The antiretroviral enzyme APOBEC3G is degraded by the proteasome in response to HIV-1 Vif. Nat Med 2003, 9(11):1404-1407. 10.1038/nm945, 14528300.
9. Yu X, Yu Y, Liu B, Luo K, Kong W, Mao P, Yu XF. Induction of APOBEC3G ubiquitination and degradation by an HIV-1 Vif-Cul5-SCF complex. Science 2003, 302(5647):1056-1060. 10.1126/science.1089591, 14564014.
10. Zhang W, Chen G, Niewiadomska AM, Xu R, Yu XF. Distinct determinants in HIV-1 Vif and human APOBEC3 proteins are required for the suppression of diverse host anti-viral proteins. PLoS One 2008, 3(12):e3963. 10.1371/journal.pone.0003963, 2597746, 19088851.
11. Armitage AE, Katzourakis A, de Oliveira T, Welch JJ, Belshaw R, Bishop KN, Kramer B, McMichael AJ, Rambaut A, Iversen AK. Conserved footprints of APOBEC3G on Hypermutated human immunodeficiency virus type 1 and human endogenous retrovirus HERV-K(HML2) sequences. J Virol 2008, 82(17):8743-8761. 10.1128/JVI.00584-08, 2519685, 18562517.
12. Kijak GH, Janini LM, Tovanabutra S, Sanders-Buell E, Arroyo MA, Robb ML, Michael NL, Birx DL, McCutchan FE. Variable contexts and levels of hypermutation in HIV-1 proviral genomes recovered from primary peripheral blood mononuclear cells. Virology 2008, 376(1):101-111. 10.1016/j.virol.2008.03.017, 18436274.
13. Land AM, Ball TB, Luo M, Pilon R, Sandstrom P, Embree JE, Wachihi C, Kimani J, Plummer FA. Human immunodeficiency virus (HIV) type 1 proviral hypermutation correlates with CD4 count in HIV-infected women from Kenya. J Virol 2008, 82(16):8172-8182. 10.1128/JVI.01115-08, 2519552, 18550667.
14. Jern P, Russell RA, Pathak VK, Coffin JM. Likely role of APOBEC3G-mediated G-to-A mutations in HIV-1 evolution and drug resistance. PLoS Pathog 2009, 5(4):e1000367. 10.1371/journal.ppat.1000367, 2659435, 19343218.
15. Sadler HA, Stenglein MD, Harris RS, Mansky LM. APOBEC3G Contributes to HIV-1 Variation Through Sublethal Mutagenesis. J Virol 2010, 84(14):7396-7404. 10.1128/JVI.00056-10, 2898230, 20463080.
16. Conticello SG, Thomas CJ, Petersen-Mahrt SK, Neuberger MS. Evolution of the AID/APOBEC family of polynucleotide (deoxy)cytidine deaminases. Mol Biol Evol 2005, 22(2):367-377.
17. Conticello SG. The AID/APOBEC family of nucleic acid mutators. Genome Biol 2008, 9(6):229. 10.1186/gb-2008-9-6-229, 2530864, 18671835.
18. Di Rienzo A, Hudson RR. An evolutionary framework for common diseases: the ancestral-susceptibility model. Trends Genet 2005, 21(11):596-601. 10.1016/j.tig.2005.08.007, 16153740.
19. Jern P, Stoye JP, Coffin JM. Role of APOBEC3 in genetic diversity among endogenous murine leukemia viruses. PLoS Genet 2007, 3(10):2014-2022. 2041998, 17967065.
20. Sawyer SL, Emerman M, Malik HS. Ancient adaptive evolution of the primate antiviral DNA-editing enzyme APOBEC3G. PLoS Biol 2004, 2(9):E275. 10.1371/journal.pbio.0020275, 479043, 15269786.
21. Bizinoto MC, Leal E, Diaz RS, Janini LM. Loci polymorphisms of the APOBEC3G gene in HIV type 1-infected Brazilians. AIDS Res Hum Retroviruses 2011, 27(2):137-141. 10.1089/aid.2010.0146, 20874421.
22. An P, Bleiber G, Duggal P, Nelson G, May M, Mangeat B, Alobwede I, Trono D, Vlahov D, Donfield S. APOBEC3G genetic variants and their influence on the progression to AIDS. J Virol 2004, 78(20):11070-11076. 10.1128/JVI.78.20.11070-11076.2004, 521814, 15452227.
23. Do H, Vasilescu A, Diop G, Hirtzig T, Heath SC, Coulonges C, Rappaport J, Therwath A, Lathrop M, Matsuda F. Exhaustive genotyping of the CEM15 (APOBEC3G) gene and absence of association with AIDS progression in a French cohort. J Infect Dis 2005, 191(2):159-163. 10.1086/426826, 15609224.
24. Janini M, Rogers M, Birx DR, McCutchan FE. Human immunodeficiency virus type 1 DNA sequences genetically damaged by hypermutation are often abundant in patient peripheral blood mononuclear cells and may be generated during near-simultaneous infection and activation of CD4(+) T cells. J Virol 2001, 75(17):7973-7986. 10.1128/JVI.75.17.7973-7986.2001, 115041, 11483742.
25. Thompson JD, Gibson TJ, Plewniak F, Jeanmougin F, Higgins DG. The CLUSTAL_X windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools. Nucleic Acids Res 1997, 25(24):4876-4882. 10.1093/nar/25.24.4876, 147148, 9396791.
26. Hasegawa M, Kishino H, Yano T. Dating of the human-ape splitting by a molecular clock of mitochondrial DNA. J Mol Evol 1985, 22(2):160-174. 10.1007/BF02101694, 3934395.
27. Guindon S, Gascuel O. A simple, fast, and accurate algorithm to estimate large phylogenies by maximum likelihood. Syst Biol 2003, 52(5):696-704. 10.1080/10635150390235520, 14530136.
28. Poon AF, Lewis FI, Pond SL, Frost SD. An evolutionary-network model reveals stratified interactions in the V3 loop of the HIV-1 envelope. PLoS Comput Biol 2007, 3(11):e231. 10.1371/journal.pcbi.0030231, 2082504, 18039027.
29. Lio P, Goldman N. Models of molecular evolution and phylogeny. Genome Res 1998, 8(12):1233-1244.
30. Yang Z. PAML 4: phylogenetic analysis by maximum likelihood. Mol Biol Evol 2007, 24(8):1586-1591. 10.1093/molbev/msm088, 17483113.
31. Tamura K, Dudley J, Nei M, Kumar S. MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0. Mol Biol Evol 2007, 24(8):1596-1599. 10.1093/molbev/msm092, 17488738.
32. Balaji S, Kalpana R, Shapshak P. Paradigm development: comparative and predictive 3D modeling of HIV-1 Virion Infectivity Factor (Vif). Bioinformation 2006, 1(8):290-309. 10.6026/97320630001290, 1891711, 17597910.
33. Anisimova M, Nielsen R, Yang Z. Effect of recombination on the accuracy of the likelihood method for detecting positive selection at amino acid sites. Genetics 2003, 164(3):1229-1236. 1462615, 12871927.
34. Martins Lde O, Leal E, Kishino H. Phylogenetic detection of recombination with a Bayesian prior on the distance between trees. PLoS One 2008, 3(7):e2651. 10.1371/journal.pone.0002651, 2440540, 18612422.
35. Bernacchi S, Henriet S, Dumas P, Paillart JC, Marquet R. RNA and DNA binding properties of HIV-1 Vif protein: a fluorescence study. J Biol Chem 2007, 282(36):26361-26368. 10.1074/jbc.M703122200, 17609216.
36. Mercenne G, Bernacchi S, Richer D, Bec G, Henriet S, Paillart JC, Marquet R. HIV-1 Vif binds to APOBEC3G mRNA and inhibits its translation. Nucleic Acids Res 2010, 38(2):633-646. 10.1093/nar/gkp1009, 2810999, 19910370.
37. Cavalieri E, Florido C, Leal E, Machado DM, Camargo M, Diaz RS, Janini LM. Intrahost and interhost variability of the HIV type 1 nef gene in Brazilian children. AIDS Res Hum Retroviruses 2009, 25(11):1129-1140. 10.1089/aid.2009.0061, 19943790.
38. Lemey P, Rambaut A, Pybus OG. HIV evolutionary dynamics within and among hosts. AIDS Rev 2006, 8(3):125-140.
39. Poon AF, Swenson LC, Dong WW, Deng W, Kosakovsky Pond SL, Brumme ZL, Mullins JI, Richman DD, Harrigan PR, Frost SD. Phylogenetic analysis of population-based and deep sequencing data to identify coevolving sites in the nef gene of HIV-1. Mol Biol Evol 2010, 27(4):819-832. 10.1093/molbev/msp289, 2877536, 19955476.
40. Chen G, He Z, Wang T, Xu R, Yu XF. A patch of positively charged amino acids surrounding the human immunodeficiency virus type 1 Vif SLVx4Yx9Y motif influences its interaction with APOBEC3G. J Virol 2009, 83(17):8674-8682. 10.1128/JVI.00653-09, 2738209, 19535450.
41. Bernacchi S, Mercenne G, Tournaire C, Marquet R, Paillart JC. Importance of the proline-rich multimerization domain on the oligomerization and nucleic acid binding properties of HIV-1 Vif. Nucleic Acids Res 2011, 39(6):2404-2415. 10.1093/nar/gkq979, 3064812, 21076154.
42. Marcsisin SR, Narute PS, Emert-Sedlak LA, Kloczewiak M, Smithgall TE, Engen JR. On the solution conformation and dynamics of the HIV-1 viral infectivity factor. J Mol Biol 2011, 410(5):1008-1022. 10.1016/j.jmb.2011.04.053, 3139145, 21763503.
43. Stanley BJ, Ehrlich ES, Short L, Yu Y, Xiao Z, Yu XF, Xiong Y. Structural insight into the human immunodeficiency virus Vif SOCS box and its role in human E3 ubiquitin ligase assembly. J Virol 2008, 82(17):8656-8663. 10.1128/JVI.00767-08, 2519636, 18562529.
44. Donahue JP, Vetter ML, Mukhtar NA, D'Aquila RT. The HIV-1 Vif PPLP motif is necessary for human APOBEC3G binding and degradation. Virology 2008, 377(1):49-53. 10.1016/j.virol.2008.04.017, 2474554, 18499212.
45. He Z, Zhang W, Chen G, Xu R, Yu XF. Characterization of conserved motifs in HIV-1 Vif required for APOBEC3G and APOBEC3F interaction. J Mol Biol 2008, 381(4):1000-1011. 10.1016/j.jmb.2008.06.061, 18619467.
46. Yang S, Sun Y, Zhang H. The multimerization of human immunodeficiency virus type I Vif protein: a requirement for Vif function in the viral life cycle. J Biol Chem 2001, 276(7):4889-4893. 10.1074/jbc.M004895200, 1350968, 11071884.
47. Wissing S, Galloway NL, Greene WC. HIV-1 Vif versus the APOBEC3 cytidine deaminases: an intracellular duel between pathogen and host restriction factors. Mol Aspects Med 2010, 31(5):383-397. 10.1016/j.mam.2010.06.001, 2967609, 20538015.
48. Leal E, Janini M, Diaz RS. Selective pressures of human immunodeficiency virus type 1 (HIV-1) during pediatric infection. Infect Genet Evol 2007, 7(6):694-707. 10.1016/j.meegid.2007.07.008, 17719854.
49. Leal E, Casseb J, Hendry M, Busch MP, Diaz RS. Relaxation of adaptive evolution during the HIV-1 infection owing to reduction of CD4+ T cell counts. PLoS One 2012, 7(6):e39776. 10.1371/journal.pone.0039776, 3387245, 22768122.
50. Russell RA, Pathak VK. Identification of two distinct human immunodeficiency virus type 1 Vif determinants critical for interactions with human APOBEC3G and APOBEC3F. J Virol 2007, 81(15):8201-8210. 10.1128/JVI.00395-07, 1951317, 17522216.
51. Walker PR, Ketunuti M, Choge IA, Meyers T, Gray G, Holmes EC, Morris L. Polymorphisms in Nef associated with different clinical outcomes in HIV type 1 subtype C-infected children. AIDS Res Hum Retroviruses 2007, 23(2):204-215. 10.1089/aid.2006.0080, 17331028.
52. Diaz RS, Leal E, Sanabani S, Sucupira MC, Tanuri A, Sabino EC, Janini LM. Selective regimes and evolutionary rates of HIV-1 subtype B V3 variants in the Brazilian epidemic. Virology 2008, 381(2):184-193. 10.1016/j.virol.2008.08.014, 18809195.
53. Simon JH, Sheehy AM, Carpenter EA, Fouchier RA, Malim MH. Mutational analysis of the human immunodeficiency virus type 1 Vif protein. J Virol 1999, 73(4):2675-2681. 104023, 10074113.